CClinicalTrials.gg
Status unknownNCT04715815Updated Jan 29, 2021

COVID-19 and Its Effects on Chronic Pain Patients

An observational study in Chronic Pain, sponsored by Prince of Songkla University. Status unknown. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-01-29.

Sponsored by Prince of Songkla University · Observational

The sponsor has not verified this record recently (last verified Jan 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
30
Ages
18 Years and older
Sex
All
01

Study summary

Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. Many factors can affect pain and its severity.

This study aims to explore how the COVID-19 affects chronic pain patients in terms of pain in general, intensity of pain, desire for pain treatment including follow up visits and pain medication refills as well as sleep.

Read the detailed description

Research question

What are the effects of the COVID-19 on chronic pain patients in terms of pain and pain management?

Conceptual framework

The COVID-19 is a novel emerging infectious disease which has unimaginable and unbelievable large scale distressing effects worldwide.

Up to date, there is no study which aims to evaluate the effects of the COVID-19 on chronic pain patients in terms of pain and pain management. The previous survey in patients focused on the worrisome of them for getting this infection and their confidence in their government to control the COVID-19 situation in the US.

Materials and methods

This study is an in-depth interview. The in-depth interview is the principal method to collect qualitative data by setting up open-ended questions beforehand. Patients who are interviewed, can express their attitudes freely. This method is flexible which words, sentences and questions can be adjusted to suit each interviewee (participant). The process consists of active and intentional listening as well as ask on an in-depth basis. All conversations during the in-depth interview are tape-recorded.

02

Conditions studied

  • Chronic Pain

Browse trials for

03

In context

Chronic Pain

2,930 studies on the registry are indexed under Chronic Pain; 701 are open to participants now.

This study's planned enrollment of 30 is below the median of 126 across 688 observational studies indexed under Chronic Pain.

Browse Chronic Pain studies →

Lead sponsor

Prince of Songkla University is the lead sponsor of 112 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patients aged 18 years and older who have chronic pain for at least 3 months' duration.

Inclusion criteria

  • Patients with chronic pain who have been under the health care service of the pain clinic of Songklanagarind hospital.
  • Chronic pain patients are patients with persistent pain for at least 3 months. Pain can be from any etiologies.
  • The expected number of interviwees for this in-depth interview is 30 or until the gathered interview data are saturated.

Exclusion criteria

Exclusion Criteria:

  • Patients who are not willing to participate this study and have time for an in person 'in-depth interview'.
  • Patients who are not influence in Thai language.
  • Patients who are physically or mentally too ill to participate this study.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
30 participants (estimated)
Patient registry
No

Interventions

  • OtherNo intervention (only interview)

    Interview

06

What researchers measure

Primary outcomes

  1. To explain how the COVID-19 affects chronic pain patients in terms of pain and pain management.

    An in-depth interview will be conducted to find out how the COVID-19 affects chronic pain patients. The investigators will measure pain intensity and sleep disturbance level by using an 11-point numerical rating scale where 0 means that the patient's pain condition is not affected by the COVID-19 and 10 means that the patient's pain condition is maximally affected. The higher the score is the worse.

    Time frame: January to December 2021

Secondary outcomes

  1. To explain how the COVID-19 affects chronic pain patients' psychological status.

    An in-depth interview will be performed to find out how the COVID-19 affects the psychological aspect of chronic pain patients. The level of anxiety and stress will be measured using the 11-point verbal numerical rating scale where 0 means that the patient's psychological status is not affected by the COVID-19 and 10 means that the patient's psychological status is maximally affected. The higher the score is the worse.

    Time frame: January to December 2021

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Wolf MS, Serper M, Opsasnick L, O'Conor RM, Curtis L, Benavente JY, Wismer G, Batio S, Eifler M, Zheng P, Russell A, Arvanitis M, Ladner D, Kwasny M, Persell SD, Rowe T, Linder JA, Bailey SC. Awareness, Attitudes, and Actions Related to COVID-19 Among Adults With Chronic Conditions at the Onset of the U.S. Outbreak: A Cross-sectional Survey. Ann Intern Med. 2020 Jul 21;173(2):100-109. doi: 10.7326/M20-1239. Epub 2020 Apr 9. PubMed 32271861 ↗

Individual participant data

Plan to share: Undecided — IPD will be shared upon request.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 29, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04715815
Lead sponsor
Prince of Songkla University
Responsible party
Sasikaan Nimmaanrat (Primary Investigator, Head of Pain Clinic, Clinical Associate Professor, Prince of Songkla University) — Principal investigator
First posted
Jan 20, 2021
Start date
Feb 2021 (estimated)
Primary completion
Dec 2021 (estimated)
Completion
Jun 2022 (estimated)
Last update
Jan 29, 2021

Study contacts

Sasikaan Nimmaanrat, MD
Contact
snimmaanrat@yahoo.com.au
+66887907842
Sasikaan Nimmaanrat, MD
principal investigator · Faculty of Medicine, Prince of Songkla University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion